MedTrace Logo

Effect of Healthy Family Program on Population Blood Pressure

NCT06427096 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8001

Last updated 2026-03-04

No results posted yet for this study

Summary

This is a 1:1 parallel design, multi-center, cluster-randomized control trial. A total of 80 villages in Ruyang County, Henan Province, China, will be randomly assigned to the intervention group or control group. At least 100 participants from 30-50 families in each village will be included in this study. The intervention group will engage in a variety of strategies, including educating a healthy lifestyle, adopting a low-sodium diet, managing weight, participating in physical exercise, monitoring blood pressure, and undergoing antihypertensive treatment. These efforts will be led by family health instructors from the community. The control group will receive usual care. The primary endpoint of this study is the change of systolic blood pressure from baseline to 6 months, reported as the difference between intervention and control group.

Conditions

  • Blood Pressure
  • Public Health

Interventions

BEHAVIORAL

Multifaceted intervention

The multifaceted interventions is comprised of the following components: 1. To establish a BP management team led by family health instructor. The team members also include family leaders and village doctors. 2. To conduct multifaceted intervention, which includes education for a healthy lifestyle, free provision of sodium substitute, weight management, physical exercise, BP monitoring, and appropriate antihypertensive treatment for individuals with hypertension.

Sponsors & Collaborators

  • National Science and Technology Major Project

    collaborator UNKNOWN

  • Heart Health Research Center

    lead OTHER

Principal Investigators

  • Jun Cai, MD · Beijing Anzhen Hospital

  • Xin Du, MD · Beijing Anzhen Hospital

  • Craig S Anderson, MD · Institute of Science and Technology for Brain-Inspired Intelligence

  • Chao Jiang, MD · Beijing Anzhen Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-23
Primary Completion
2025-02-12
Completion
2025-07-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06427096 on ClinicalTrials.gov